| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Division of Cardiology, Emory University, Atlanta, Ga.
Correspondence to Charles D. Searles, Division of Cardiology, Emory University, 1639 Pierce Dr, WMB 319, Atlanta, GA 30322. E-mail csearle{at}emory.edu
Posttranscriptional regulation of endothelial nitric oxide synthase (eNOS) expression is an important mechanism by which endothelial cells respond to various physiological and pathophysiological stimuli. Previously, we showed that eNOS expression was dramatically altered by the state of cell growth and that the mechanism responsible for this regulation was entirely posttranscriptional, occurring via changes in eNOS mRNA stability. The present study identifies a role for actin cytoskeleton organization in the posttranscriptional regulation of eNOS during cell growth and examines the relationship between the state of actin polymerization and eNOS expression. We identified monomeric actin (globular [G]-actin) as the major component of a 51-kDa ribonucleoprotein that binds to the eNOS mRNA 3' untranslated region in UV-crosslinking analysis. Binding activity of the ribonucleoprotein complex correlated with the relative concentration of G-actin versus filamentous actin (F-actin). ENOS transcripts colocalized with cytoplasmic G-actin in cells subjected to fluorescence in situ hybridization and G-actin fluorescence staining. In subcellular fractionation studies, eNOS transcripts were enriched in the free polysomal fraction of nonproliferating cells and enriched in the cell matrix-associated polysomal fraction of proliferating cells. Furthermore, an inverse relationship between the concentration of G-actin and eNOS expression was observed in endothelial cells subjected to pharmacological alteration of their cytoskeleton; lower G/F-actin ratios correlated with increased eNOS expression. Our findings provide some insight into how endothelial cells may use the dynamic organization of the actin cytoskeleton to regulate expression of an enzyme that is crucial to vascular homeostasis.
Key Words: endothelial nitric oxide synthase mRNA binding protein mRNA stability 3' untranslated region cytoskeletal dynamics
This article has been cited by other articles:
![]() |
M. Sverdlov, V. Shinin, A. T. Place, M. Castellon, and R. D. Minshall Filamin A Regulates Caveolae Internalization and Trafficking in Endothelial Cells Mol. Biol. Cell, November 1, 2009; 20(21): 4531 - 4540. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Balligand, O. Feron, and C. Dessy eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues Physiol Rev, April 1, 2009; 89(2): 481 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Oberleithner, C. Callies, K. Kusche-Vihrog, H. Schillers, V. Shahin, C. Riethmuller, G. A. MacGregor, and H. E. de Wardener Potassium softens vascular endothelium and increases nitric oxide release PNAS, February 24, 2009; 106(8): 2829 - 2834. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Youn, T. Wang, and H. Cai An Ezrin/Calpain/PI3K/AMPK/eNOSs1179 Signaling Cascade Mediating VEGF-Dependent Endothelial Nitric Oxide Production Circ. Res., January 2, 2009; 104(1): 50 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yan, B. You, S.-P. Chen, J. K. Liao, and J. Sun Tumor Necrosis Factor-{alpha} Downregulates Endothelial Nitric Oxide Synthase mRNA Stability via Translation Elongation Factor 1-{alpha} 1 Circ. Res., September 12, 2008; 103(6): 591 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cai, D. Liu, and J. G.N. Garcia CaM Kinase II-dependent pathophysiological signalling in endothelial cells Cardiovasc Res, January 1, 2008; 77(1): 30 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kosmidou, J. P. Moore, M. Weber, and C. D. Searles Statin Treatment and 3' Polyadenylation of eNOS mRNA Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2642 - 2649. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Su, D. Kondrikov, and E. R. Block beta-Actin: A Regulator of NOS-3 Sci. Signal., September 18, 2007; 2007(404): pe52 - pe52. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J.G. Horrevoets Profilin-1: An Unexpected Molecule Linking Vascular Inflammation to the Actin Cytoskeleton Circ. Res., August 17, 2007; 101(4): 328 - 330. [Full Text] [PDF] |
||||
![]() |
D. M. Dudzinski and T. Michel Life history of eNOS: Partners and pathways Cardiovasc Res, July 15, 2007; 75(2): 247 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Searles Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression Am J Physiol Cell Physiol, November 1, 2006; 291(5): C803 - C816. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. van Thienen, J. O. Fledderus, R. J. Dekker, J. Rohlena, G. A. van IJzendoorn, N. A. Kootstra, H. Pannekoek, and A. J.G. Horrevoets Shear stress sustains atheroprotective endothelial KLF2 expression more potently than statins through mRNA stabilization Cardiovasc Res, November 1, 2006; 72(2): 231 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nguyen and H. Cai Netrin-1 induces angiogenesis via a DCC-dependent ERK1/2-eNOS feed-forward mechanism PNAS, April 25, 2006; 103(17): 6530 - 6535. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Andreeva, R. Vaiskunaite, M. A. Kutuzov, J. Profirovic, R. A. Skidgel, and T. Voyno-Yasenetskaya Novel Mechanisms of G Protein-Dependent Regulation of Endothelial Nitric-Oxide Synthase Mol. Pharmacol., March 1, 2006; 69(3): 975 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kondrikov, H.-R. Han, E. R. Block, and Y. Su Growth and density-dependent regulation of NO synthase by the actin cytoskeleton in pulmonary artery endothelial cells Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L41 - L50. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weber, C. H. Hagedorn, D. G. Harrison, and C. D. Searles Laminar Shear Stress and 3' Polyadenylation of eNOS mRNA Circ. Res., June 10, 2005; 96(11): 1161 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Brandes Statin-Mediated Inhibition of Rho: Only to Get More NO? Circ. Res., May 13, 2005; 96(9): 927 - 929. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |